Perspective Therapeutics
Clinical trials sponsored by Perspective Therapeutics, explained in plain language.
-
New Alpha-Particle therapy shows promise for Tough-to-Treat melanoma
Disease control Recruiting nowThis study tests a new treatment called [212Pb]VMT01, which delivers targeted radiation to melanoma cells. It is for people with advanced melanoma that has not responded to prior therapies. The trial will evaluate safety and effectiveness when given alone or with the immunotherap…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New Alpha-Particle therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is testing a new treatment that uses a radioactive substance to target and destroy cancer cells in people with advanced solid tumors (like pancreatic, stomach, or ovarian cancer) that have not responded to standard treatments. The therapy works by attaching to a protei…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New Alpha-Particle therapy shows promise for Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new treatment called [212Pb]VMT-α-NET for people with advanced tumors that have a specific marker (SSTR2). The treatment delivers targeted radiation to kill cancer cells while sparing healthy tissue. The study involves up to 300 adults with neuroendocrine tumor…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:04 UTC